{
    "Overall_score": {
        "Correlation": 8,
        "Sentiment": 7,
        "Importance": 8,
        "Impact": 7,
        "Duration": 6,
        "Virality": 5,
        "Source_Score": 8,
        "Specificity": 7,
        "Sector_Spread": 6,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "MRK : Earlier than expected Lung Cancer Filing limited to PDL1 High Patients",
            "Correlation": 9,
            "Sentiment": 7,
            "Importance": 8,
            "Impact": 7,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 7,
            "Specificity": 8,
            "Sector_Spread": 5,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Merck Cancer Drug Shines Against Skin, Lung Cancer MRK BMY",
            "Correlation": 8,
            "Sentiment": 8,
            "Importance": 9,
            "Impact": 8,
            "Duration": 6,
            "Virality": 6,
            "Source_Score": 8,
            "Specificity": 7,
            "Sector_Spread": 7,
            "Tech_Mentions": 3
        },
        {
            "News_content": "Merckâ€™s Hepatitis C Therapy Regains FDA 'Breakthrough' Status Merck MRK",
            "Correlation": 9,
            "Sentiment": 8,
            "Importance": 8,
            "Impact": 7,
            "Duration": 7,
            "Virality": 5,
            "Source_Score": 9,
            "Specificity": 8,
            "Sector_Spread": 6,
            "Tech_Mentions": 2
        },
        {
            "News_content": "The Keytruda lung cancer study was profiled on the NBC Nightly News this evening. Word is getting out. MRK",
            "Correlation": 8,
            "Sentiment": 7,
            "Importance": 7,
            "Impact": 6,
            "Duration": 5,
            "Virality": 7,
            "Source_Score": 8,
            "Specificity": 6,
            "Sector_Spread": 5,
            "Tech_Mentions": 1
        },
        {
            "News_content": "Most Active Healthcare Stocks: AbbVie Inc. (NYSE:ABBV), Merck & Co. Inc... MRK",
            "Correlation": 6,
            "Sentiment": 5,
            "Importance": 5,
            "Impact": 4,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 6,
            "Specificity": 5,
            "Sector_Spread": 8,
            "Tech_Mentions": 1
        },
        {
            "News_content": "MRK: Keytruda Shows Improved Survival Odds in Melanoma - WSJ",
            "Correlation": 9,
            "Sentiment": 8,
            "Importance": 8,
            "Impact": 7,
            "Duration": 6,
            "Virality": 6,
            "Source_Score": 9,
            "Specificity": 8,
            "Sector_Spread": 6,
            "Tech_Mentions": 2
        }
    ]
}